Susquehanna International Group
ROIV icon

Susquehanna International Group’s Roivant Sciences ROIV Stock Holding History

Susquehanna International Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Sell
370,100
-993,700
-73% -$25.5M ﹤0.01% 3079
2025
Q4 		$29.6M Buy
1,363,800
+350,300
+35% +$6.91M ﹤0.01% 1836
2025
Q3 		$15.3M Buy
1,013,500
+725,700
+252% +$8.98M ﹤0.01% 2492
2025
Q2 		$3.24M Buy
287,800
+63,500
+28% +$688K ﹤0.01% 4814
2025
Q1 		$2.26M Sell
224,300
-49,700
-18% -$537K ﹤0.01% 5246
2024
Q4 		$3.24M Sell
274,000
-93,200
-25% -$1.1M ﹤0.01% 4331
2024
Q3 		$4.24M Sell
367,200
-153,200
-29% -$1.74M ﹤0.01% 3878
2024
Q2 		$5.5M Buy
520,400
+115,000
+28% +$1.26M ﹤0.01% 3297
2024
Q1 		$4.27M Sell
405,400
-891,100
-69% -$9.61M ﹤0.01% 3896
2023
Q4 		$14.6M Buy
1,296,500
+878,100
+210% +$8.56M ﹤0.01% 2154
2023
Q3 		$4.89M Buy
418,400
+137,700
+49% +$1.56M ﹤0.01% 3569
2023
Q2 		$2.83M Buy
280,700
+127,000
+83% +$1.14M ﹤0.01% 4469
2023
Q1 		$1.13M Buy
153,700
+12,400
+9% +$102K ﹤0.01% 6484
2022
Q4 		$1.13M Buy
+141,300
New +$786K ﹤0.01% 5899

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's ROIV Position: Q1 2026 in Review

Susquehanna International Group reduced its Roivant Sciences (ROIV) stake by 85% in Q1 2026, selling an estimated $28M and leaving 196,195 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Susquehanna International Group first reported a position in ROIV in Q4 2021 and has held it in 17 quarters since. The position peaked at $27.9M in Q4 2025. 441 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Susquehanna International Group held 196,195 shares of Roivant Sciences worth $5.43M as of Q1 2026.
  • Susquehanna International Group sold 1,090,002 Roivant Sciences shares in Q1 2026, an estimated $28M.
  • Roivant Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4087 holding.
  • Susquehanna International Group first reported a position in Roivant Sciences in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Roivant Sciences position peaked at $27.9M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.